Advertisement
THC vs UHS
Which Stock Would AI Choose? Tenet Healthcare Corporation (THC) vs. Universal Health Services, Inc. (UHS) Stock Comparison
Key Takeaways
- THC has delivered stronger recent momentum, driven by rapid growth in its ambulatory surgery platform, while UHS is expanding through behavioral health and virtual care.
- Tenet trades at a notably lower price-to-earnings (P/E) multiple than its healthcare peers, whereas Universal Health carries a more modest valuation gap.
- Both companies face similar cost and payer-mix headwinds, but Tenet's high-acuity and ambulatory mix has supported faster earnings growth.
- UHS is pursuing a transformational acquisition of virtual behavioral health provider Talkspace, a catalyst not present in Tenet's near-term pipeline.
- Relative performance and trend consistency currently favor THC, though UHS offers a differentiated diversification angle into behavioral health.
Introduction
Investors comparing hospital operators often weigh Tenet Healthcare Corporation and Universal Health Services, Inc. as two of the most prominent publicly traded names in the sector. This stock comparison is relevant for traders and investors seeking exposure to healthcare services, whether through acute care hospitals, outpatient surgery, or behavioral health. Although both companies operate in the same broad industry, their business mixes, growth drivers, and market positioning differ meaningfully. Understanding their relative performance and recent developments can help clarify which profile may align better with different investment objectives in the current market environment.
THC Overview and Recent Performance
Tenet Healthcare Corporation is a Dallas-based healthcare services provider operating through two main segments: Hospital Operations and Services, and Ambulatory Care. Its ambulatory division, operated through United Surgical Partners International (USPI), has become a central growth engine, spanning hundreds of ambulatory surgery centers and surgical hospitals across the United States. Through its Conifer subsidiary, Tenet also provides revenue cycle management services.
In recent weeks, THC has outperformed the broader medical sector, with strong year-to-date gains and a multi-year share price advance that has drawn increased analyst attention. This relative performance has been supported by growth in higher-acuity services, same-facility revenue per case, and disciplined expense management. Tenet has also raised its 2026 adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) outlook and expanded its share repurchase authorization, which have reinforced sentiment. However, the stock's extended run has prompted debate over whether its valuation now fully reflects its earnings trajectory.
UHS Overview and Recent Performance
Universal Health Services, Inc., headquartered in King of Prussia, Pennsylvania, is one of the nation's largest hospital and healthcare services providers. The company operates acute care hospitals, a large network of inpatient behavioral health facilities, and outpatient care sites across the United States, the United Kingdom, and Puerto Rico. Its behavioral health segment is a defining characteristic of its business model.
In recent market activity, UHS has posted solid revenue and earnings growth, with both its acute care and behavioral health segments contributing. The company's recent decision to acquire Talkspace, a virtual behavioral health platform, signals a strategic push into outpatient and digital care. At the same time, UHS has navigated cost pressures, softer volumes in certain periods, and a more measured earnings outlook, which has contributed to somewhat less pronounced share price momentum than Tenet. The company continues to return capital through share repurchases while investing in capacity expansion.
Trending AI Robots
For traders seeking a more systematic approach to this kind of stock comparison, Tickeron's Trending AI Robots page offers a curated view of the platform's AI trading bots. Tickeron maintains hundreds of AI trading bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance statistics, and set of symbols. Because not every bot suits every market condition, only the most relevant and best-performing strategies are highlighted in the Trending AI Robots section. This makes it easier for users to identify bots aligned with current market dynamics rather than searching through the full catalog. Explore the Trending AI Robots page to review available strategies and their performance metrics.
Head-to-Head Comparison
The most significant contrast between the two companies lies in their business models. Tenet has increasingly oriented itself around ambulatory surgery, where higher-acuity outpatient procedures and favorable payer dynamics support stronger margins and faster growth. Universal Health Services, by contrast, derives a substantial portion of its identity from inpatient behavioral health, a segment with distinct demand drivers, reimbursement characteristics, and regulatory exposure.
On growth drivers, Tenet's USPI platform has delivered double-digit revenue growth, while UHS is banking on the Talkspace acquisition and freestanding behavioral facilities to capture outpatient demand. In terms of recent momentum, THC has shown greater relative strength, while UHS has demonstrated steadier, more measured gains. Risk factors overlap, including labor costs, supply expense inflation, and payer-mix shifts tied to health insurance exchange enrollment, but UHS also carries behavioral health-specific regulatory considerations. From a market sentiment standpoint, Tenet's lower P/E multiple and stronger earnings trajectory have attracted more bullish analyst positioning, whereas UHS is often viewed as a more diversified, defensively oriented operator.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative performance, and the strength of near-term catalysts, Tickeron's AI would likely lean toward THC in the current environment. The combination of robust ambulatory growth, upwardly revised guidance, and stronger price momentum suggests a more favorable trend profile than UHS at present. That said, UHS's diversification into behavioral health and its virtual care expansion could improve its relative positioning over a longer horizon. This assessment reflects probabilistic trend analysis rather than a definitive prediction, and positioning could shift as new earnings data and catalysts emerge.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is THC is a Buy and UHS is a Hold.
THC in +1.37% Uptrend, advancing for three consecutive days on November 11, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where THC advanced for three days, in 266 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on THC as a result. In 64 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for THC just turned positive on November 04, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 34 of 44 cases over the following month. The odds of a continued upward trend are 77%.
THC moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 214 of 264 cases where THC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for THC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator moved out of overbought territory. In 34 of the 54 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
THC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.898) is normal, around the industry mean (204.532). P/E Ratio (10.872) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).
UHS in +12.12% Uptrend, advancing for three consecutive days on November 05, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UHS advanced for three days, in 240 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on UHS as a result. In 65 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for UHS just turned positive on November 04, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 28 of 43 cases over the following month. The odds of a continued upward trend are 65%.
UHS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for UHS moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Aroon Indicator entered an Uptrend today. In 214 of 298 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Bearish Trend Analysis
The 10-day RSI Indicator for UHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 23 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
UHS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.533) is normal, around the industry mean (204.532). P/E Ratio (7.893) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.154) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
THC | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 10 | 57 | |
SMR RATING 1..100 | 20 | 45 | |
PRICE GROWTH RATING 1..100 | 38 | 44 | |
P/E GROWTH RATING 1..100 | 68 | 77 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (61) in the Hospital Or Nursing Management industry is in the same range as THC (69). This means that UHS’s stock grew similarly to THC’s over the last 12 months.
THC's Profit vs Risk Rating (10) in the Hospital Or Nursing Management industry is somewhat better than the same rating for UHS (57). This means that THC’s stock grew somewhat faster than UHS’s over the last 12 months.
THC's SMR Rating (20) in the Hospital Or Nursing Management industry is in the same range as UHS (45). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
THC's Price Growth Rating (38) in the Hospital Or Nursing Management industry is in the same range as UHS (44). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
THC's P/E Growth Rating (68) in the Hospital Or Nursing Management industry is in the same range as UHS (77). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
| THC | UHS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 63% | 1 day ago 52% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 69% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 65% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 70% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 70% |
| Advances ODDS (%) | 1 day ago 82% | 7 days ago 72% |
| Declines ODDS (%) | 6 days ago 66% | 15 days ago 66% |
| BollingerBands ODDS (%) | 1 day ago 56% | 1 day ago 55% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 72% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
THC’s FA Score shows that 2 FA rating(s) are green while UHS’s FA Score has 0 green FA rating(s).
- THC’s FA Score: 2 green, 3 red.
- UHS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
THC’s TA Score shows that 6 TA indicator(s) are bullish while UHS’s TA Score has 6 bullish TA indicator(s).
- THC’s TA Score: 6 bullish, 4 bearish.
- UHS’s TA Score: 6 bullish, 4 bearish.
Price Growth
THC (@Hospital/Nursing Management) experienced а +0.25% price change this week, while UHS (@Hospital/Nursing Management) price change was +0.16% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.72%. For the same industry, the average monthly price growth was +0.44%, and the average quarterly price growth was +11.06%.
Reported Earning Dates
THC is expected to report earnings on Feb 11, 2027.
UHS is expected to report earnings on Mar 03, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-5.72% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
THC and
Correlation & Price change
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.
UHS and
Correlation & Price change
A.I.dvisor indicates that over the last year, UHS has been closely correlated with HCA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % | ||
|---|---|---|---|---|
| UHS | 100% | +0.70% | ||
| HCA - UHS | 68% Closely correlated | +0.32% | ||
| THC - UHS | 57% Loosely correlated | +0.93% | ||
| CHE - UHS | 43% Loosely correlated | +1.13% | ||
| PNTG - UHS | 42% Loosely correlated | +0.16% | ||
| ENSG - UHS | 41% Loosely correlated | +0.59% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HBMX | 19.08 | 1.43 | +8.10% |
| Tuttle Capital Concentrated Memory Stack ETF (HBMX) | |||
| CVLC | 94.21 | 1.21 | +1.30% |
| Calvert US Large-Cap Core Responsible Index ETF (CVLC) | |||
| ITDG | 42.19 | 0.42 | +1.01% |
| iShares LifePath Target Date 2055 ETF (ITDG) | |||
| UJAN | 46.71 | 0.31 | +0.67% |
| Innovator U.S. Equity Ultra Buffer ETF - January (UJAN) | |||
| IEFA | 97.43 | 0.27 | +0.28% |
| iShares Core MSCI EAFE ETF (IEFA) | |||